These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 7710429)
21. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy. Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107 [TBL] [Abstract][Full Text] [Related]
22. Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2. Li T; Fujita Y; Tsuda Y; Miyazaki A; Ambo A; Sasaki Y; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y J Med Chem; 2005 Jan; 48(2):586-92. PubMed ID: 15658871 [TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage. Marastoni M; Balboni G; Salvadori S; Sarto GP; Tomatis R Arzneimittelforschung; 1985; 35(11):1630-2. PubMed ID: 4091867 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and opioid activity of novel tetrapeptides analogous to sequence (1-4) of dermorphin. Naqvi T; Raghubir R; Haq W; Tripathi A; Patnaik GK; Mathur KB Neuropeptides; 1998 Aug; 32(4):333-8. PubMed ID: 10102678 [TBL] [Abstract][Full Text] [Related]
25. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling. Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993 [TBL] [Abstract][Full Text] [Related]
26. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat. Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890 [TBL] [Abstract][Full Text] [Related]
27. Opioid ligands with extraordinarily high mu-selectivity: dermorphin tetrapeptides containing thymine-modified alanine residues. Kharkevich DA; Sumbatyan NV; Topin AN; Chichenkov ON; Zaitsev SV; Korshunova GA FEBS Lett; 1994 Sep; 351(3):308-10. PubMed ID: 7915993 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and opioid activity of dermorphin tetrapeptides bearing D-methionine S-oxide at position 2. Salvadori S; Marastoni M; Balboni G; Sarto GP; Tomatis R J Med Chem; 1986 Jun; 29(6):889-94. PubMed ID: 2872334 [TBL] [Abstract][Full Text] [Related]
29. Dermorphin and deltorphin heptapeptide analogues: replacement of Phe residue by Dmp greatly improves opioid receptor affinity and selectivity. Ambo A; Murase H; Niizuma H; Ouchi H; Yamamoto Y; Sasaki Y Bioorg Med Chem Lett; 2002 Mar; 12(6):879-81. PubMed ID: 11958984 [TBL] [Abstract][Full Text] [Related]
30. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. Kreil G; Barra D; Simmaco M; Erspamer V; Erspamer GF; Negri L; Severini C; Corsi R; Melchiorri P Eur J Pharmacol; 1989 Mar; 162(1):123-8. PubMed ID: 2542051 [TBL] [Abstract][Full Text] [Related]
31. New features of the delta opioid receptor: conformational properties of deltorphin I analogues. Balboni G; Marastoni M; Picone D; Salvadori S; Tancredi T; Temussi PA; Tomatis R Biochem Biophys Res Commun; 1990 Jun; 169(2):617-22. PubMed ID: 2162669 [TBL] [Abstract][Full Text] [Related]
32. Opioid peptides. Structure-activity relationships in [beta-Ala4]dermorphin tetrapeptides. V. Salvadori S; Marastoni M; Tomatis R; Sarto G Farmaco Sci; 1983 Sep; 38(9):640-6. PubMed ID: 6641929 [TBL] [Abstract][Full Text] [Related]
33. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues. Bryant SD; Guerrini R; Salvadori S; Bianchi C; Tomatis R; Attila M; Lazarus LH J Med Chem; 1997 Aug; 40(16):2579-87. PubMed ID: 9258365 [TBL] [Abstract][Full Text] [Related]
34. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors. Gaudriault G; Zsürger N; Vincent JP J Neurochem; 1997 Feb; 68(2):813-9. PubMed ID: 9003073 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptors. Gacel GA; Fellion E; Baamonde A; Dauge V; Roques BP Peptides; 1990; 11(5):983-8. PubMed ID: 1980943 [TBL] [Abstract][Full Text] [Related]
38. Opioid peptides. Biological study of [D-MetO2] dermorphin analogues in relation to the plurality of opioid receptors. XI. Marastoni M; Salvadori S; Tomatis R; Borea PA; Bertelli G Farmaco Sci; 1987 Feb; 42(2):125-31. PubMed ID: 3032674 [TBL] [Abstract][Full Text] [Related]
39. Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS). Vonhof S; Barone FC; Price WJ; Paakkari P; Millison JH; Feuerstein GZ; Sirén AK Eur J Pharmacol; 2001 Mar; 416(1-2):83-93. PubMed ID: 11282116 [TBL] [Abstract][Full Text] [Related]
40. Dermorphin interaction with peripheral opioid receptors. Giagnoni G; Parolaro D; Casiraghi L; Crema G; Sala M; Andreis C; Gori E Neuropeptides; 1984 Dec; 5(1-3):157-60. PubMed ID: 6099487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]